ArticleFrontiers in oncology2022

Anti-CD19 chimeric antigen receptor T-cell followed by interferon-α therapy induces durable complete remission in donor cell-derived acute lymphoblastic leukemia: A case report.

Jing Ni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.